Yahoo Finance Surgery Partners Third Quarter 2022 Earnings: Misses Expectations
Surgery Partners (NASDAQ:SGRY) Third Quarter 2022 Results
Key Financial Results
Revenue: US$620.6m (up 11% from 3Q 2021).
Net loss: US$25.0m (loss widened by 9.2% from 3Q 2021).
US$0.28 loss per share.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Surgery Partners Revenues and Earnings Miss Expectations
Revenue missed analyst estimates by 2.3%. Earnings per share (EPS) also missed analyst estimates significantly.
Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 7.5% growth forecast for the Healthcare industry in the US.
Performance of the American Healthcare industry.
The company's shares are down 12% from a week ago.
Balance Sheet Analysis
While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. We have a graphic representation of Surgery Partners' balance sheet and an in-depth analysis of the company's financial position.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here
